Stock & Company Details
Actinium Pharmaceuticals Inc $ATNM
Price:
N/A
N/A
31M
$43M
52 Week High:
N/A
10 Day Average Volume:
N/A
-2.03
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ATNM technical indicators
Latest Actinium Pharmaceuticals Inc (ATNM) indicator readings as of 2026-10-29.
ATNM's 14-day RSI is 64.3, in neutral territory. At $1.53 it is trading 36.7% above its 200-day moving average of $1.12, and above its 50-day average of $1.19. Price sits near the upper Bollinger Band ($0.86 to $1.63). ADX reads 30.8, indicating a trending market.
Overview
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells safely and effectively. Its most advanced products are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
Finance Bot
Ask your questions
Start by typing a question below.
